StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3056% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer BeneFIX [legacy through FY24] by Year

BeneFIX (coagulation factor IX) [legacy through FY24] — Worldwide reported YoY (%) (%)

Pfizer BeneFIX [legacy through FY24]: -10.0% in FY2024, up 7.0 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2024
-10.0%
Period ended Dec 31, 2024
Change on a year earlier
+7.0 pts
-17.0% in FY2023
History
8 years
Since FY2017
Sources
8
Documents cited below

Where the FY2024 figure comes from

“|| BeneFIX | 381 | 424 | (10%) | (8%) | 200 | 225 | (11%) | 181 | 200 | (9%) | (5%)”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗

Reported in Form 8-K Revenue Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Pfizer BeneFIX [legacy through FY24] (%), annual FY2017–FY2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/benefix-leg-yoy-ww

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.